Apellis Pharmaceuticals, Inc. (APLS)
40.90
+0.03
(+0.07%)
USD |
NASDAQ |
Apr 17, 16:00
40.90
0.00 (0.00%)
Pre-Market: 20:00
Apellis Pharmaceuticals Total Liabilities (Quarterly) : 705.11M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Eli Lilly & Co. | 85.94B |
| Agios Pharmaceuticals, Inc. | 104.11M |
| Scholar Rock Holding Corp. | 158.78M |
| Kezar Life Sciences, Inc. | 6.574M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.075B |
| Shareholders Equity (Quarterly) | 370.15M |
| Debt to Equity Ratio | 1.282 |
| Current Ratio | 3.136 |
| Net Debt Paydown Yield | -0.02% |